BR112022016197A2 - Polipeptídeos e seus usos - Google Patents

Polipeptídeos e seus usos

Info

Publication number
BR112022016197A2
BR112022016197A2 BR112022016197A BR112022016197A BR112022016197A2 BR 112022016197 A2 BR112022016197 A2 BR 112022016197A2 BR 112022016197 A BR112022016197 A BR 112022016197A BR 112022016197 A BR112022016197 A BR 112022016197A BR 112022016197 A2 BR112022016197 A2 BR 112022016197A2
Authority
BR
Brazil
Prior art keywords
polypeptides
nanoparticles
designing
disclosed
methods
Prior art date
Application number
BR112022016197A
Other languages
English (en)
Portuguese (pt)
Inventor
P King Neil
Walkey Carl
Yang Wang Jing
FIALA Brooke
Veesler David
C Walls Alexandra
NATTERMANN Una
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of BR112022016197A2 publication Critical patent/BR112022016197A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/20—Protein or domain folding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/50—Mutagenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Theoretical Computer Science (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
BR112022016197A 2020-02-14 2021-02-12 Polipeptídeos e seus usos BR112022016197A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062977036P 2020-02-14 2020-02-14
PCT/US2021/017856 WO2021163481A1 (en) 2020-02-14 2021-02-12 Polypeptides and their use

Publications (1)

Publication Number Publication Date
BR112022016197A2 true BR112022016197A2 (pt) 2022-10-25

Family

ID=77292738

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022016197A BR112022016197A2 (pt) 2020-02-14 2021-02-12 Polipeptídeos e seus usos

Country Status (10)

Country Link
US (1) US20230075095A1 (cg-RX-API-DMAC7.html)
EP (1) EP4103586A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023513592A (cg-RX-API-DMAC7.html)
KR (1) KR20220142471A (cg-RX-API-DMAC7.html)
AU (1) AU2021220958A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022016197A2 (cg-RX-API-DMAC7.html)
CL (2) CL2022002215A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022011395A2 (cg-RX-API-DMAC7.html)
PE (1) PE20230486A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021163481A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114933657B (zh) * 2021-08-25 2024-02-02 上海交通大学医学院 神经生长因子突变体重组蛋白及其应用
KR102527221B1 (ko) * 2021-10-15 2023-05-02 에스케이바이오사이언스 주식회사 단백질의 정제방법
US20250215055A1 (en) * 2022-04-07 2025-07-03 University Of Washington Secretion-optimized de novo designed protein nanoparticles for eukaryotic expression and genetic delivery
WO2024218715A1 (en) 2023-04-19 2024-10-24 Btl Healthcare Technologies A.S. Culture media based on protein hydrolysate and a process for preparing thereof
AU2024265411A1 (en) 2023-05-01 2025-11-06 University Of Washington Pre-fusion-stabilized cmv gb protein nanostructures
AR133824A1 (es) * 2023-09-15 2025-11-05 Icosavax Inc Proteínas virales y nanoestructuras y usos de estas
US12668774B2 (en) 2023-10-12 2026-06-30 Btl Healthcare Technologies A.S. Product, system and method of cell cultivation
WO2025144636A1 (en) * 2023-12-26 2025-07-03 The Scripps Research Institute ENGINEERED hMPV F PROTEIN IMMUNOGENS AND RELATED VACCINES
WO2025207938A1 (en) * 2024-03-29 2025-10-02 University Of Washington Nucleic acid vaccines against coccidioidomycosis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2568788A1 (en) * 2004-06-16 2005-12-29 Dsm Ip Assets B.V. Production of polypeptides by improved secretion
US9630994B2 (en) * 2014-11-03 2017-04-25 University Of Washington Polypeptides for use in self-assembling protein nanostructures
WO2016138525A1 (en) * 2015-02-27 2016-09-01 University Of Washington Polypeptide assemblies and methods for the production thereof
WO2016199898A1 (ja) * 2015-06-10 2016-12-15 公立大学法人 富山県立大学 活性型変異酵素の製造方法および新規活性型変異酵素、並びに可溶性化変異タンパク質の製造方法
WO2018047856A1 (ja) * 2016-09-06 2018-03-15 学校法人慶應義塾 融合タンパク質、構造体、捕集剤、捕集する方法、dna、及びベクター
US11866699B2 (en) * 2017-02-10 2024-01-09 University Of Washington Genome editing reagents and their use
EP3606942B1 (en) * 2017-04-04 2025-06-11 University of Washington Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus f proteins and their use
CN112088014B (zh) * 2018-02-28 2026-03-24 华盛顿大学 自组装纳米结构疫苗
AU2019285048B2 (en) * 2018-06-13 2023-06-08 The Scripps Research Institute Nanoparticle vaccines with novel structural components
FR3083804B1 (fr) * 2018-07-13 2022-08-12 Institut Nat Des Sciences Appliquees De Toulouse Micro-organismes et procede pour la production d'acide glycolique a partir de pentoses et d'hexoses

Also Published As

Publication number Publication date
JP2023513592A (ja) 2023-03-31
EP4103586A1 (en) 2022-12-21
KR20220142471A (ko) 2022-10-21
PE20230486A1 (es) 2023-03-21
WO2021163481A1 (en) 2021-08-19
CL2022002215A1 (es) 2023-05-05
AU2021220958A1 (en) 2022-09-01
EP4103586A4 (en) 2024-05-15
US20230075095A1 (en) 2023-03-09
CO2022011395A2 (es) 2023-01-16
CL2025002147A1 (es) 2026-03-06

Similar Documents

Publication Publication Date Title
BR112021022874A2 (pt) Proteínas de ligação epcam e métodos de uso
MX2025001828A (es) Proteinas de fusion interleucina-2/receptor alfa de interleucina-2 y metodos de uso
MX2020003504A (es) Receptores de celulas t que reconocen p53 mutado.
MY202182A (en) Flt3l-fc fusion proteins and methods of use
BR112022006842A2 (pt) Construtos de igf2 variante
DK1356052T3 (da) Produktion af hele antistoffer i prokaryotiske celler
BR112018070250A2 (pt) linhagem celular para proteína recombinante e/ou produção de vetores virais
EA202092093A1 (ru) Композиции и способы перепрограммирования tcr с применением слитых белков
EA202090931A2 (ru) Композиции и способы перепрограммирования tcr с помощью гибридных белков
MY204756A (en) Factor viii chimeric proteins and uses thereof
EA201791918A1 (ru) Модификация белков клеток-хозяев
MX2018013882A (es) Seleccion directa de celulas que expresan niveles altos de proteinas heterodimericas usando vectores de complementacion intragenica de glutamina sintetasa.
CO2022011395A2 (es) Polipéptidos y sus usos
BR112022004562A2 (pt) Método de seleção de doador universal para identificar doadores de células nk
WO2019236943A3 (en) Methods for generating hematopoietic stem cells
BR112022003852A2 (pt) Métodos de preparação de células t para terapia de células t
CR20210478A (es) Proteínas de fusión, bacterias recombinantes, y fragmentos de exosporio para el control de plagas y salud vegetal
BR112022013442A2 (pt) Métodos e composições para produção de células de ilhotas xenogênicas e tratamento de condições resistentes ou deficientes à insulina com os mesmos
CL2023001433A1 (es) Muteína de il-2; proteína de fusión; ácido nucleico; vector; célula hospedera; métodos; uso
BR112021022900A2 (pt) Expressão de proteínas modificadas em peroxissoma
BR112018076674A2 (pt) proteína de fusão entre o fator de viabilidade do cone derivado de bastonetes de forma curta e um peptídeo hidrofílico
EP4317175A4 (en) TRUNCATED TACI POLYPEPTIDE AND FUSION PROTEIN AND THEIR USES
EP4745138A1 (en) THIO-GLUTARIMIDO ISOINDOLINONE DERIVATIVE, BIFUNCTIONAL PROTEIN DEGRADING AGENT: CONTAINER AND USES
BR112021019139A2 (pt) Célula de mamífero manipulada, composição, molécula isolada de dna de fita dupla, dispositivo implantável, cápsula de hidrogel, e, método de tratamento de um paciente com doença de fabry
EP4491633A4 (en) PD-L1 SPECIFIC CHIMERIC ANTIGENIC RECEPTOR AND IMMUNE CELL CONTAINING IT